Biomarker-Driven NSCLC Care: The Precision Medicine Model for Today and the Future

Download these slides from a live webinar for the most recent data on the best methods for molecular testing in NSCLC.

Sandip P. Patel, MD Released: April 11, 2022

Download these slides from a live webinar for a review of recent data on treatment selection for patients with EGFR- or KRAS-positive NSCLC.

Joshua Sabari, MD Released: April 11, 2022

Download these slides from a live webinar for the most recent data on optimal treatment approaches for patients with NSCLC that are positive for less common driver mutations, including ALK, ROS, RET, NTRK, and MET.

Todd M. Bauer, MD Released: April 11, 2022

In this on-demand webcast from a recent AACR satellite symposium, expert faculty highlight the use of biomarkers to guide treatment choices in non-small-cell lung cancer, including new data, recent approvals, and treatment guidelines.

Todd M. Bauer, MD Sandip P. Patel, MD Joshua Sabari, MD Physicians: maximum of 1.75 AMA PRA Category 1 Credits™ Released: May 12, 2022 Expired: May 11, 2023

Three experts review current molecular testing in NSCLC and discuss how they apply biomarkers to guide care of patients with targeted agents in real-world clinical practice.

Todd M. Bauer, MD Sandip P. Patel, MD Joshua Sabari, MD Released: May 26, 2022